Upregulation of the PTGS1 and PTGS2 pathways of arachidonic acid (AA) is thought to be involved in the development of rheumatic diseases, and targeting these pathways might lead to improved treatment strategies11. Here, PTGS2 is linked to rheumatic disorder.